Prospective study on the prevalence and associated risk factors of cryptorchidism in 6246 newborn boys from Nice area, France

International Journal of Andrology

Volumn 34, Issue 5 PART 2, 2011, Pages

  Wagner Mahler, K ^a   Kurzenne, J Y ^a   Delattre, I ^b   Berard E ^a   Mas, J C ^a   Bornebush, L ^c   Tommasi, C ^c   Boda Buccino, M ^d   Ducot, B ^e   Boulle C ^a   Ferrari, P ^f   Azuar, P ^g   Bongain, A ^d   Fenichel P ^d,e   Brucker Davis, F ^d,e  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b Lab Dept de Prehistoire du Lazaret   (France)

^c Pediatrics Department CHG Grasse   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e INSERM   (France)

^f University Hospital of Nice University of Nice Sophia Antipolis   (France)

^g CHG Grasse   (France)

Author keywords

Cryptorchidism; Environment; Epidemiology; Evolution; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; PARACETAMOL; PHTHALIC ACID DERIVATIVE; POLYCHLORINATED BIPHENYL;

AMBIGUOUS GENITALIA; AMENORRHEA; ARTICLE; CONTROLLED STUDY; CRYPTORCHISM; DRUG USE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FATHER; FOLLOW UP; FOOD INTAKE; FRANCE; FRUIT; GESTATIONAL AGE; HUMAN; HYPOSPADIAS; INCIDENCE; INGUINAL HERNIA; INSTRUMENTAL DELIVERY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MATERNAL NUTRITION; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MICROPENIS; MOTHER; NEWBORN; NEWBORN SCREENING; OCCUPATION; OCCUPATIONAL EXPOSURE; PEDIATRICIAN; PREGNANCY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RECURRENT DISEASE; RISK ASSESSMENT; SEASONAL VARIATION; UROGENITAL TRACT MALFORMATION;

CASE-CONTROL STUDIES; CRYPTORCHIDISM; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; PREGNANCY; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 81155159621     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2011.01211.x     Document Type: Article

References (60)

1. Acerini CL, Miles HL, Dunger DB, Ong KK & Hughes IA. (2009) The descriptive epidemiology of congenital and acquired cryptorchidism in a UK infant cohort. Arch Dis Child 94, 868-872.
2. Adeoti ML, Fadiora SO, Oguntola AS, Aderounmu AO, Laosebikan DA & Adejumobi OO. (2004) Cryptorchidism in a local population in Nigeria. West Afr J Med 23, 62-64.
3. Akre O & Richiardi L. (2009) Does a testicular dysgenesis syndrome exist? Hum Reprod 24, 2053-2060.
4. Akre O, Lipworth L, Cnattingius S, Sparen P & Ekbom A. (1999) Risk factor patterns for cryptorchidism and hypospadias. Epidemiology 10, 364-369.
5. Andersen HR, Schmidt IM, Grandjean P, Jensen TK, Budtz-Jørgensen E, Kjaerstad MB, Baelum J, Nielsen JB, Skakkebaek NE & Main KM. (2008) Impaired reproductive development in sons of women occupationally exposed to pesticides during pregnancy. Environ Health Perspect 116, 566-572.
6. Ars E, Lo Giacco D, Bassas L, Nuti F, Rajmil O, Ruiz P, Garat JM, Ruiz-Castané E & Krausz C. (2010) Further insights into the role of T222P variant of RXFP2 in non-syndromic cryptorchidism in two Mediterranean populations. Int J Androl [Epub ahead of print]. doi:10.1111/j. 1365-2605.2010.01088.x
7. Barthold JS & Gonzalez R. (2003) The epidemiology of congenital cryptorchidism, testicular ascent and orchidopexy. J Urol 170, 2396-2401.
8. Berkowitz GS & Lapinski RH. (1996) Risk factors for cryptorchidism: a nested case-control study. Paediatr Perinat Epidemiol 10, 39-51.
9. Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA & Holzman IR. (1993) Prevalence and natural history of cryptorchidism. Pediatrics 92, 44-49.
10. Berkowitz GS, Lapinski RH, Godbold JH, Dolgin SE & Holzman IR. (1995) Maternal and neonatal risk factors for cryptorchidism. Epidemiology 6, 127-133.
11. Biggs ML, Baer A & Critchlow CW. (2002) Maternal, delivery, and perinatal characteristics associated with cryptorchidism: a population-based case-control study among births in Washington State. Epidemiology 13, 197-204.
12. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM & Schmidt IM. (2004) Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363, 1250-1251.
13. Brucker-Davis F, Wagner-Mahler K, Delattre I, Ducot B, Ferrari P, Bongain A, Kurzenne JY, Mas JC, Fenichel P & the Cryptorchidism Study Group from Nice Area. (2008) Cryptorchidism at birth in Nice area (France) is associated with higher prenatal exposure to PCBs and DDE, as assessed by colostrum concentrations. Hum Reprod 23, 1708-1718.
14. Carlsen E, Giwercman A, Keiding N & Skakkebaek NE. (1995) Declining semen quality and increasing incidence of testicular cancer: is there a common cause? Environ Health Perspect 103(Suppl. 7), 137-139.
15. Chilvers C, Pike MC, Forman D, Fogelmaman K & Wadsworth MEJ. (1984) Apparent doubling of frequency of undescended testis in England and Wales in 1962-1981. Lancet II, 330-332.
16. Cook MB, Akre O, Forman D, Madigan MP, Richiardi L & Mc Glynn KA. (2010) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer - experiences of the son. Int J Epidemiol 39, 1605-1618.
17. Cortes D, Kjellberg EM, Breddam M & Thorup J. (2008) The true incidence of cryptorchidism in Denmark. J Urol 179, 314-318.
18. Damgaard IN, Skakkebaek NE, Toppari J, Virtanen HE, Shen H & Schramm KW. (2006) Persistent pesticides in human breast milk and cryptorchidism. Environ Health Perspect 114, 1133-1138.
19. Damgaard IN, Jensen TK, The Nordic Cryptorchidism Study Group, Petersen JH, Skakkebaek NE, Toppari J & Main KM. (2008) Risk factors for congenital cryptorchidism in a prospective birth cohort study. PLoS ONE 3, e3051.
20. Duvie SO, Evbuomwan I, Scott-Emuakpor AB & Kadiri I. (1990) Familial occurrence of cryptorchidism. West Afr J Med 9, 321-323.
21. Elert A, Jahn K, Heidenreich A & Hofmann R. (2003) The familial undescended testis. Klin Pedia 215, 40-45.
22. Ferlin A, Bogatcheva NV, Gianesello L, Pepe A, Vinanzi C, Agoulnik AI & Foresta C. (2006) Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization. Mol Hum Reprod 12, 401-406.
23. Fisher JS. (2004) Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. Reproduction 127, 305-315.
24. Ghirri P, Ciulli C, Vuerich M, Cuttano A, Faraoni M, Guerrini L, Spinelli C, Tognetti S & Boldrini A. (2002) Incidence at birth and natural history of cryptorchidism: a study of 10, 730 consecutive male infants. J Endocrinol Invest 25, 709-715.
25. Giordano F, Carbone P, Nori F, Mantovani A, Taruscio D & Figa-Talamanca I. (2008) Maternal diet and the risk of hypospadias and cryptorchidism in the offspring. Paediatr Perinat Epidemiol 22, 249-260.
26. Hadziselimovic F. (2002) Cryptorchidism: its impact on male fertility. Eur Urol 41, 121-123.
27. Hjertkvist M, Damber JE & Bergh A. (1989) Cryptorchidism: a registry based study in Sweden on some factors of possible aetiological importance. J Epidemiol Community Health 43, 324-329.
28. Jackson MB. (1988) The epidemiology of cryptorchidism. The John Radcliffe Hospital Cryptorchidism Research group. Horm Res 30, 153-156.
29. Jensen MS, Bonde JP & Olsen J. (2007a) Prenatal alcohol exposure and cryptorchidism. Acta Paediatr 11, 1681-1685.
30. Jensen MS, Toft G, Thulstrup AM, Bonde JP & Olsen J. (2007b) Cryptorchidism according to maternal gestational smoking. Epidemiology 18, 220-225.
31. Jensen MS, Rebordosa C, Thulstrup AM, Toft G, Sorensen HT, Bonde JP, Henriksen TB & Olsen J. (2010) Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology 21, 779-785.
32. Kaleva M, Virtanen HE, Haavisto A-M, Main KM, Reunanen M, Skakkebaek NE & Toppari J. (2005) Circannual rhythm in the incidence of cryptorchidism in Finland. Int J Androl 28, 53-57.
33. Kristensen DM, Hass U, Lesné L, Lottrup G, Jacobsen PR, Desdoits-Lethimonier C et al. (2011) Intra-uterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 26, 235-244.
34. Krysiak-Baltyn K, Toppari J, Skakkebaek NE, Jensen TS, Virtanen HE, Schramm KW et al. (2010) Country-specific chemical signatures of persistent compounds in breast milk. Int J Androl 33, 270-278.
35. Longnecker MP, Klebanoff MA, Brock JW, Zhou H, Gray KA, Needham LL & Wilcox AJ. (2002) Maternal serum level of 1, 1-dichloro-2, 2-bis(p-chlorophenyl)ethylene and risk of cryptorchidism, hypospadias, and polythelia among male offspring. Am J Epidemiol 155, 313-322.
36. Lottrup G, Andersson AM, Leffers H, Mortensen GK, Toppari J, Skakkebaek NE & Main KM. (2006) Possible impact of phthalates on infant reproductive health. Int J Androl 29, 172-180.
37. Mahood IK, Scott HM, Brown R, Hallmark N, Walker M & Sharpe RM. (2007) In utero exposure to di(n-butyl) phthalate and testicular dysgenesis: comparison of fetal and adult end points and their dose sensitivity. Environ Health Perspect 115(Suppl. 1), 55-61.
38. Main KM, Toppari J, Suomi A-M, Kaleva M, Chellakooty M, Schmidt IM et al. (2006) Larger testes and higher inhibin B levels in Finnish than in Danish newborn boys. J Clin Endocrinol Metab 91, 2732-2737.
39. Main KM, Kiviranta H, Virtanen HE, Sundqvist E, Tuomisto JT, Tuomisto J, Vartiainen T, Skakkebaek NE & Toppari J. (2007) Flame retardants in placenta and breast milk and cryptorchidism in newborn boys. Environ Health Perspect 115, 1519-1526.
40. Main KM, Skakkebaek NE, Virtanen HE & Toppari J. (2010) Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab 24, 279-289.
41. Mansour SA. (2009) Persistent organic pollutants (POPs) in Africa: Egyptian scenario. Hum Exp Toxicol 28, 531-566.
42. Marsee K, Woodruff TJ, Axelrad DA, Calafat AM & Swan SH. (2006) Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced ano-genital distance. Environ Health Perspect 114, 805-809.
43. Martin OV, Shialis T, Lester JN, Scrimshaw MD, Boobis AR & Voulvoulis N. (2008) Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis. Environ Health Perspect 116, 149-157.
44. Mc Glynn KA, Guo X, Graubard BI, Brock JW, Klebanoff MA & Longnecker MP. (2009) Maternal pregnancy levels of polychlorinated biphenyls and risk of hypospadias and cryptorchidism in male offspring. Environ Health Perspect 9, 1472-1476.
45. Mongraw-Chaffin ML, Cohen RD, Cohn BA & Christianson RE. (2008) Maternal smoking, alcohol consumption, and caffeine consumption during pregnancy in relation to a son's risk of persistent cryptorchidism: a prospective study in the Child Health and Development Studies cohort, 1959-1967. Am J Epidemiol 167, 257-261.
46. Nakanishi T. (2008) Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor. J Toxicol Sci 33, 269-276.
47. North K, Golding J & ASPAC Study group.. (2000) A maternal vegetable diet in pregnancy is associated with hypospadias. BJU Int 85, 107-113.
48. Paulozzi JL. (1999) International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect 107, 297-302.
49. Pierik FH, Burdorf A, Deddens JA, Juttmann RE & Weber RFA. (2004) Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environ Health Perspect 112, 1570-1576.
50. Pierik FH, Burdorf A, de Muinck Keizer-Schrama SM, Wolffenbuttel KP, Nijman JM, Juttmann RE & Weber RF. (2005) The cryptorchidism prevalence among infants in the general population of Rotterdam, the Netherlands. Int J Androl 28, 248-252.
51. Preiksa RT, Zilaitiene B, Matulevicius V, Skakkebaek NE, Petersen JH & Jorgensen N. (2005) Higher than expected prevalence of congenital cryptorchidism in Lithuania: a study of 1204 boys at birth and 1year follow-up. Hum Reprod 20, 1928-1932.
52. Scorer CG. (1964) The descent of the testis. Arch Dis Child 39, 605-615.
53. Skakkebaek NE. (2003) Testicular dysgenesis syndrome. Horm Res 60(Suppl. 3), 49.
54. Strandberg-Larsen K, Jensen MS, Ramlau-Hansen CH, Gronbaek M & Olsen J. (2009) Alcohol binge drinking during pregnancy and cryptorchidism. Hum Reprod 24, 3211-3219.
55. Thonneau PF, Gandia P & Mieusset R. (2003) Cryptorchidism: incidence, risk factors, and potential role of environment: an update. J Androl 24, 155-162.
56. Thorup J, Cortes D & Petersen BL. (2006) The incidence of bilateral cryptorchidism is increased and the fertility potential is reduced in sons born to mothers who have smoked during pregnancy. J Urol 176, 734-737.
57. Toppari J, Kaleva M & Virtanen HE. (2001) Trends in the incidence of cryptorchidism and hypospadias and methodological limitations of registry-based data. Hum Reprod Update 7, 282-286.
58. Virtanen HE, Tapanainen AE, Kaleva MM, Suomi AM, Main KM, Skakkebaek NE & Toppari J. (2006) Mild gestational diabetes as a risk factor for congenital cryptorchidism. J Clin Endocrinol Metab 91, 4862-4865.
59. Wagner-Mahler K, Kurzenne JY, Delattre I, Bongain A, Brucker-Davis F, Berard E & Fenichel P. (2010) Incidence of cryptorchidism at birth: a prospective study at the University Hospital of Nice. Presse Med 39, 981-982.
60. Weidner IS, Moller H, Jensen TK & Skakkebaek NE. (1998) Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect 106, 793-796.